Peptide Vaccines and Cancer
Synthetic peptide vaccines can be individually synthesized into therapeutic cancer vaccines. In this case, peptides from tumor-associated antigens are used to trigger effective anti-tumor immune response. This therapy has been shown to be a helpful adjunct in cancer treatment. Genetic information from a patient, as well as tumor material are helpful in designing an individualized anti-cancer peptide vaccine.